BioLine RX Ltd (NASDAQ:BLRX)

2.00
Delayed Data
As of Aug 11
 -0.11 / -5.21%
Today’s Change
1.06
Today|||52-Week Range
3.64
-11.11%
Year-to-Date
Institutional investors control 26.95% of the outstanding shares in BLRX. This represents a greater percentage of ownership than at almost any other company in the Pharmaceuticals: Other industry. Additionally, during the quarter ended March 2019, these large investors purchased a net $2.3 million shares.
Other institutional25.57%
Mutual fund holders1.37%
Individual stakeholders--

Largest Quarterly Institutional
Transactions

Latest Institutional Activity

5/26/2020SABBY CAPITAL LLC  Bought 1.1 Million shares of BioLine RX Ltd
5/26/2020ARMISTICE CAPITAL LLC  Bought 1.0 Million shares of BioLine RX Ltd
6/30/2020PSAGOT MUTUAL FUNDS LTD.  Bought 117.0 Thousand shares of BioLine RX Ltd

Top 10 Owners of BioLine RX Ltd

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
BVF Partners LP8.77%1,733,0362,963,49200.00%
Sabby Capital LLC5.78%1,142,8571,954,285+1,080,939+1,745.76%
Armistice Capital LLC5.25%1,038,0841,775,124+1,038,084--
Senvest Management LLC2.65%523,819895,730-104,743-16.66%
Morgan Stanley & Co. LLC1.47%289,709495,402+67,936+30.63%
Medical Strategy GmbH1.19%234,809401,523+20,881+9.76%
Psagot Mutual Funds Ltd.0.59%117,000200,070+117,000--
OrbiMed Advisors LLC0.35%69,240118,40000.00%
Morgan Stanley Smith Barney LLC (...0.27%54,20092,682+19,986+58.41%
Jane Street Capital LLC0.26%52,04388,994+52,043--

Top 10 Mutual Funds Holding BioLine RX Ltd

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
FCP Medical - BioHealth1.16%228,396390,557+23,215+11.31%
APO Medical Opportunities Institu...0.07%14,13324,16700.00%
Pharma/wHealth Fund0.07%13,22022,606-2,400-15.36%
RIM Global - Bioscience0.03%6,41310,966-2,334-26.68%
Fidelity Nasdaq Composite Index F...0.03%5,7729,87000.00%
Abante Global Funds - Biotech Fun...0.02%3,6676,271+3,667--